Literature DB >> 26999570

Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease.

Mehmet Kadri Akboga1, Kevser Gulcihan Balci1, Orhan Maden1, Ahmet Goktug Ertem1, Ozgur Kirbas1, Cagri Yayla1, Burak Acar1, Dursun Aras1, Halil Kisacik1, Sinan Aydogdu1.   

Abstract

AIM: We aimed to investigate whether baseline monocyte to high-density lipoprotein cholesterol ratio (MHR), an easily available inflammatory and oxidative stress marker, is associated with SYNTAX score. PATIENTS &
METHODS: In this cross-sectional study, n = 1229 consecutive patients with coronary artery disease were classified into two groups, low SYNTAX score (≤22) and high SYNTAX score (≥23).
RESULTS: MHRs were significantly higher in patients with high SYNTAX score (p < 0.05). In multivariate regression analysis, MHR remained as independent predictor of high SYNTAX score together with C-reactive protein (CRP), hypertension and diabetes mellitus. In correlation analysis, MHR showed significant positive correlations with SYNTAX score (r = 0.371, p < 0.001) and CRP level (r = 0.336, p < 0.001).
CONCLUSION: This study suggests MHR is independently associated with burden of coronary atherosclerosis.

Entities:  

Keywords:  high SYNTAX score; inflammation/oxidative stress; monocyte/HDL-cholesterol ratio

Mesh:

Substances:

Year:  2016        PMID: 26999570     DOI: 10.2217/bmm-2015-0050

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  23 in total

1.  Novel inflammatory biomarkers for predicting high SYNTAX score.

Authors:  M K Akboga; O Kirbas; C Yayla
Journal:  Herz       Date:  2016-06-22       Impact factor: 1.443

2.  The ratio of monocyte frequency to HDL cholesterol level as a predictor of asymptomatic organ damage in patients with primary hypertension.

Authors:  Emel Aydin; Ihsan Ates; Mehmet Fettah Arikan; Nisbet Yilmaz; Fatih Dede
Journal:  Hypertens Res       Date:  2017-03-09       Impact factor: 3.872

3.  The association between thrombotic and inflammatory biomarkers and lower-extremity peripheral artery disease.

Authors:  Savas Celebi; Berkten Berkalp; Basri Amasyali
Journal:  Int Wound J       Date:  2020-05-22       Impact factor: 3.315

4.  Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.

Authors:  Mehmet Kadri Akboğa; Samet Yılmaz; Rıdvan Yalçın
Journal:  Anatol J Cardiol       Date:  2021-11       Impact factor: 1.596

5.  Correlation between monocyte to high-density lipoprotein ratio and major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.

Authors:  Rong Yu; Ruigang Hou; Tong Wang; Tianliang Li; Huiyuan Han; Jian An
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

6.  A New Marker of Myocardial Bridge?

Authors:  Paolo Blanco Villela; Gláucia Maria Moraes de Oliveira
Journal:  Arq Bras Cardiol       Date:  2019-01       Impact factor: 2.000

7.  Assessment of the Relationship between Monocyte to High-Density Lipoprotein Ratio and Myocardial Bridge.

Authors:  Asim Enhos; Kahraman Cosansu; Mustafa Ahmet Huyut; Fahrettin Turna; Erdem Karacop; Nijad Bakshaliyev; Aydin Nadir; Ramazan Ozdemir; Mahmut Uluganyan
Journal:  Arq Bras Cardiol       Date:  2018-12-17       Impact factor: 2.000

8.  A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.

Authors:  Fatih Mehmet Ucar
Journal:  BMC Cardiovasc Disord       Date:  2016-10-03       Impact factor: 2.298

9.  The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome.

Authors:  Akin Usta; Eyup Avci; Cagla Bahar Bulbul; Hasan Kadi; Ertan Adali
Journal:  Reprod Biol Endocrinol       Date:  2018-04-10       Impact factor: 5.211

10.  A New Inflammatory Marker: Elevated Monocyte to HDL Cholesterol Ratio Associated with Smoking.

Authors:  Mücahid Yılmaz; Hidayet Kayançiçek
Journal:  J Clin Med       Date:  2018-04-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.